Trends in methadone-related deaths in Zurich

Patrick Johannes Laberke1, Christine Bartsch

  • 1Institute of Legal Medicine, University of Basel, Pestalozzistr. 22, 4056, Basel, Switzerland. patrick.laberke@bs.ch

Insights

Methadone fatalities in Zurich (1998-2007) primarily resulted from illicit use or substitution programs, not analgesic use. Combined drug intoxication was common, with alcohol and cocaine frequently involved.

Area of Science:

  • Forensic Toxicology
  • Clinical Pharmacology
  • Public Health

Background:

  • Methadone is widely used for opioid addiction treatment and increasingly as an analgesic for chronic pain.
  • Fatalities have been reported with methadone use, necessitating investigation into its safety profile.
  • Previous studies have documented methadone-related deaths, highlighting the need for ongoing surveillance.

Purpose of the Study:

  • To analyze trends in methadone-associated fatalities in Zurich from 1998 to 2007.
  • To determine the circumstances and causes of methadone-related deaths.
  • To compare findings with a previous study period (1989-1997) for a comprehensive 19-year analysis.

Main Methods:

  • Retrospective analysis of all methadone-associated deaths reported in Zurich.
  • Inclusion of data from a prior study (1989-1997) to extend the observation period.
  • Categorization of deaths based on methadone's role (substitution, illicit intake, analgesic use) and presence of co-intoxicants.

Main Results:

  • A total of 146 methadone-associated deaths were identified between 1998 and 2007.
  • The majority of deaths were linked to substitution programs or illicit methadone intake.
  • Only three deaths were attributed to methadone used as an analgesic; combined drug intoxication (76%) was frequent, with alcohol and cocaine as common co-intoxicants.

Conclusions:

  • Methadone-associated fatalities in Zurich are predominantly linked to its use in substitution therapy or illicit consumption.
  • Deaths solely due to methadone intoxication are rare, especially when used as prescribed for pain relief.
  • The high prevalence of combined drug intoxication underscores the risks associated with polydrug use in conjunction with methadone.

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Drug Dependence01:17

Drug Dependence

Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...